Shalby Ltd

₹ 146 -2.67%
05 Dec 4:01 p.m.
About

Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of the company is to offer tertiary and quaternary healthcare services to patients in various areas of specialization such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, rental transplantations, etc.[1]

Key Points

Hospitals Portfolio
Presently, the company operates 11 hospitals across India with a total bed capacity of ~2,100 beds.
It also owns 50 outpatient clinics across 15 states in India and 5 OP clinics in African Countries.[1]
It undertook aggressive expansion and has operationalised 6 new hospitals since FY15. It also has 2 hospitals under construction.[2]

  • Market Cap 1,572 Cr.
  • Current Price 146
  • High / Low 156 / 95.0
  • Stock P/E 24.0
  • Book Value 83.1
  • Dividend Yield 0.66 %
  • ROCE 9.50 %
  • ROE 6.53 %
  • Face Value 10.0

Pros

  • Company has been maintaining a healthy dividend payout of 21.7%
  • Debtor days have improved from 68.0 to 52.7 days.

Cons

  • Company has a low return on equity of 5.13% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
126 121 109 38 116 132 145 192 182 162 163 202 202
98 99 106 43 86 101 114 154 152 134 139 162 165
Operating Profit 28 22 3 -5 29 31 31 38 29 28 24 40 37
OPM % 22% 18% 2% -13% 26% 23% 21% 20% 16% 17% 15% 20% 18%
2 2 10 2 2 2 2 3 3 -2 4 4 5
Interest 1 2 2 1 1 1 1 1 2 2 2 2 2
Depreciation 9 9 9 9 9 9 9 9 11 11 11 12 12
Profit before tax 20 14 2 -13 22 23 23 31 19 14 15 31 29
Tax % 35% 41% 1,005% 31% -12% 26% 58% 34% 44% 6% 34% 34% 36%
Net Profit 13 8 -17 -9 24 17 10 20 11 13 10 20 18
EPS in Rs 1.20 0.75 -1.58 -0.81 2.27 1.56 0.91 1.87 1.00 1.20 0.95 1.86 1.70
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
259 275 290 324 378 461 487 431 699 728
196 207 235 252 299 379 404 342 577 599
Operating Profit 63 68 56 71 79 82 83 89 122 129
OPM % 24% 25% 19% 22% 21% 18% 17% 21% 17% 18%
2 2 2 7 10 10 17 8 8 12
Interest 2 5 10 11 12 8 7 5 8 7
Depreciation 11 21 11 17 23 33 36 37 43 46
Profit before tax 52 43 36 50 54 50 57 55 79 88
Tax % 28% 43% -1% 43% 27% 37% 51% 23% 32%
Net Profit 38 25 36 29 39 32 28 42 54 62
EPS in Rs 11.17 7.36 4.30 3.40 3.65 2.93 2.55 3.93 5.01 5.71
Dividend Payout % 0% 0% 0% 0% 0% 17% 20% 25% 20%
Compounded Sales Growth
10 Years: %
5 Years: 17%
3 Years: 15%
TTM: 12%
Compounded Profit Growth
10 Years: %
5 Years: 14%
3 Years: 21%
TTM: 14%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 14%
1 Year: 6%
Return on Equity
10 Years: %
5 Years: 5%
3 Years: 5%
Last Year: 7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
35 35 88 87 108 108 108 108 108 107
Reserves 106 133 117 164 643 672 691 727 768 790
37 98 224 328 114 71 62 44 155 139
39 85 76 99 96 89 105 118 162 169
Total Liabilities 217 351 504 679 961 939 967 997 1,194 1,205
130 175 319 323 650 692 672 660 675 666
CWIP 5 91 82 221 47 3 6 8 6 5
Investments 0 0 0 0 0 11 28 16 25 25
81 85 102 134 264 233 260 314 488 509
Total Assets 217 351 504 679 961 939 967 997 1,194 1,205

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
60 14 43 55 79 19
-153 -236 1 -31 -51 -60
96 222 -51 -22 -30 90
Net Cash Flow 3 0 -6 3 -2 49

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 21 29 40 38 49 64 71 80 53
Inventory Days 77 113 113 105 242 1,063
Days Payable 395 462 499 415 606 621
Cash Conversion Cycle 21 29 40 -280 -299 -321 -239 -283 495
Working Capital Days 35 -46 -26 -34 -3 23 70 84 110
ROCE % 22% 13% 12% 9% 7% 7% 7% 10%

Shareholding Pattern

Numbers in percentages

4 recently
Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
79.43 79.44 79.44 79.45 79.45 79.45 74.07 74.02 74.02 74.02 74.04 74.04
5.16 3.68 0.52 0.66 0.79 0.84 3.68 4.17 3.83 3.95 3.92 3.78
0.84 0.65 1.03 0.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.28
13.64 15.30 18.08 18.63 18.83 18.78 21.32 20.88 21.22 21.10 21.12 20.97
0.93 0.93 0.93 0.93 0.93 0.93 0.93 0.93 0.93 0.93 0.93 0.93

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents

Concalls